1 Min Read
April 20 (Reuters) - Glenmark Pharmaceuticals Ltd:
* GETS ANDA APPROVAL FOR CLOBETASOL PROPIONATE TOPICAL SOLUTION USP
* SAYS PRODUCT WILL BE MANUFACTURED AT CO'S BADDI PLANT IN INDIA Source text - bit.ly/2F0WQol Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.